Filenews 28 January 2021
At the request of the Commission, the Federal Medicines Agency carried out an inspection at astraZeneca's vaccine production site in Belgium, the Belgian newspaper De Standaard reports, adding that this is confirmed by the office of Health Minister Frank Vandenbruke. The aim is "to make sure that the delay in delivery of vaccines is actually due to a production problem at the Belgian plant", according to the Office of the Minister of Health.
The inspection, De Standaard notes, was carried out in cooperation with other countries, "so that there is full transparency and objectivity," says a spokesman for Vandenbruke, adding that "Belgian experts are now examining the data collected, along with experts from the Netherlands, Italy and Spain." At the same time, as the article states, a report will be drawn up as soon as possible, although it may take 'a few days'.
Source: eyenews/ethnos.com.au
